sur Onco-Innovations Limited (isin : CA68237C1059)
Onco-Innovations' Inka Health Enters EOI with Quantify Research
Onco-Innovations Limited has announced an Expression of Interest between its subsidiary, Inka Health, and Quantify Research. This agreement focuses on synergizing data analytics in oncology research, utilizing AI-driven predictive modeling for enhanced cancer treatment insights.
Quantify Research, known for its expertise in healthcare data analytics, aims to support the development of SynoGraph™, Inka's platform for precision medicine. The collaboration will involve refining SynoGraph™ models with real-world data from various clinical sources, ensuring compliance with privacy regulations.
This EOI aligns with Onco-Innovations' mission to transform cancer research. By leveraging Quantify's experience, Inka Health hopes to innovate oncology treatments and improve patient outcomes through data-driven insights.
R. H.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Onco-Innovations Limited